More than 9,000 patients were seen at St. Jude, most of whom are treated on a continuing outpatient basis as part of ongoing research programs and account for approximately 75,000 hospital visits per year.
6,863 patients are enrolled in the St. Jude LIFE program, a research study that brings St. Jude childhood cancer survivors back to the hospital for regular health screenings.
Around 750 sickle cell patients are being treated in the St. Jude Sickle Cell program.
471 students attended the St. Jude school program in fiscal year 2025.
26 Child Life Specialists are on staff. The Child Life Program reduces stress and anxiety by helping children cope with the challenges of health care and hospitalization in an age-appropriate way.
Our Give To Live Society members help St. Jude focus on what matters most.
Kinlee's journey with medulloblastoma shows how research in the labs at St. Jude can translate to better outcomes for patients.
St. Jude scientists helped lead a comprehensive genomic analysis to uncover the impact of genes on the treatment and outcome of the world’s most common childhood cancer.
Pioneering work in St. Jude labs provides "promising" path to a cure using gene editing.
Saving future generations of St. Jude kids
For questions about St. Jude Give To Live Society, call (800) 214-0654, email gtlsocietysupport@alsac.stjude.org, or visit our FAQs.
St. Jude patient Reagan
Other ways to renew your Give To Live Society membership in 2024: